Disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Kanji Forex Pvt Ltd has submitted the disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 199212-04-2013
12-04-2013
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Vijayaben Kanji Ashra has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201112-04-2013
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Bliss GVS Pharma Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199212-04-2013
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Bliss GVS Pharma Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199212-04-2013
Disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Vijayaben Kanji Ashra has submitted the disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 199212-04-2013
Fixes Record Date for Interim Dividend
Bliss GVS Pharma Ltd has informed BSE that the Record Date for payment of Interim dividend will be February 26, 2013.14-02-2013
Board declares Interim Dividend
Bliss GVS Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 13, 2013, inter alia, has declared an Interim Dividend of 30% i.e. Re. 0.30 per equity share for the year 2012-2013.13-02-2013
Financial Results & Limited Review for Dec 31, 2012
Bliss GVS Pharma Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended December 31, 2012.13-02-2013
Board to consider Dividend
Bliss GVS Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 13, 2013, inter alia to consider, the Un-audited Financial Results for the Quarter ended December 31, 2012 and Dividend if any.06-02-2013
Financial Results & Limited Review for Sep 30, 2012
Bliss GVS Pharma Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended September 30, 2012.09-11-2012